Edelweiss MSCI I D W H 45 Index Fund G
Summary Info
Fund Name
: Edelweiss Mutual Fund
Scheme Name
: Edelweiss MSCI I D W H 45 Index Fund G
AMC
: Edelweiss Mutual Fund
Type
: Open
Category
: Equity - Index
Launch Date
: 06-Oct-2020
Fund Manager
: Bhavesh Jain
Net Assets (Rs. cr)
: 167.84
Edelweiss MSCI I D W H 45 Index Fund G - Nav Details
Nav Date
: 10-Dec-2025
NAV [Rs.]
: 20.5485
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Edelweiss MSCI I D W H 45 Index Fund G- NAV Chart
Edelweiss MSCI I D W H 45 Index Fund G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.4 | 0.99 | 3.22 | 6.41 | 4.4 | 17.87 | 13.44 | 14.98 |
| Category Avg | -1.5 | -0.14 | 2.33 | 0.55 | -0.49 | 15.96 | 15.4 | 9.41 |
| Category Best | 1.62 | 8.58 | 19.86 | 23.57 | 26.35 | 34.24 | 23.55 | 35.01 |
| Category Worst | -4.85 | -8.2 | -8.58 | -18.44 | -19.87 | 10.51 | 12.59 | -19.58 |
Edelweiss MSCI I D W H 45 Index Fund G- Latest Dividends
No Records Found
Edelweiss MSCI I D W H 45 Index Fund G- Investment Details
Min. Investment(Rs.)
: 100
Increm.Investment(Rs.)
: 100
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.50 | 110227 | 20.18 |
| Foreign Equity | ELI LILLY & CO | Pharmaceuticals | 6.83 | 1246 | 11.98 |
| Equity | Max Healthcare | Healthcare Services | 5.92 | 89332 | 10.38 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.66 | 64943 | 9.94 |
| Equity | Apollo Hospitals | Healthcare Services | 5.18 | 12386 | 9.08 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 5.06 | 13721 | 8.88 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 4.47 | 62305 | 7.84 |
| Foreign Equity | JOHNSON & JOHNSON | Pharmaceuticals | 3.93 | 3728 | 6.90 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 3.42 | 28853 | 6.00 |
| Foreign Equity | ABBVIE INC | Biotechnology | 3.17 | 2735 | 5.57 |
| Equity | Fortis Health. | Healthcare Services | 2.95 | 56361 | 5.18 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.88 | 13605 | 5.06 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 2.37 | 40301 | 4.15 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.10 | 30018 | 3.68 |
| Foreign Equity | MERCK & CO.INC | Pharmaceuticals | 2.07 | 3868 | 3.62 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.98 | 17827 | 3.46 |
| Foreign Equity | NOVARTIS AG | Pharmaceuticals | 1.96 | 2943 | 3.43 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 1.82 | 14222 | 3.20 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.78 | 5493 | 3.12 |
| Foreign Equity | ABBOTT LABORATORIES | Health Care Equipment & Supplies | 1.77 | 2694 | 3.10 |
| Foreign Equity | THERMO FISHER SCIENTIFIC INC | Life Sciences Tools & Services | 1.76 | 585 | 3.09 |
| Foreign Equity | INTUITIVE SURGICAL INC | Health Care Equipment & Supplies | 1.62 | 556 | 2.85 |
| Foreign Equity | AMGEN INC | Biotechnology | 1.47 | 834 | 2.57 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.39 | 61422 | 2.44 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.33 | 16024 | 2.32 |
| Foreign Equity | Novo Nordisk A/S | Pharmaceuticals & Biotechnology | 1.25 | 4984 | 2.20 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 1.24 | 23114 | 2.17 |
| Foreign Equity | GILEAD SCIENCES INC | Biotechnology | 1.23 | 1921 | 2.16 |
| Foreign Equity | DANAHER CORP | Health Care Equipment & Supplies | 1.15 | 998 | 2.02 |
| Foreign Equity | MEDTRONIC PLC | Health Care Equipment & Supplies | 1.07 | 1986 | 1.87 |
| Foreign Equity | STRYKER CORP | Health Care Equipment & Supplies | 1.01 | 533 | 1.76 |
| Equity | Narayana Hrudaya | Healthcare Services | 0.91 | 8215 | 1.59 |
| Foreign Equity | VERTEX PHARMACEUTICALS INC | Biotechnology | 0.88 | 398 | 1.54 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 0.85 | 8515 | 1.49 |
| Equity | Syngene Intl. | Healthcare Services | 0.77 | 20826 | 1.35 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 0.73 | 68701 | 1.28 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 0.73 | 5022 | 1.28 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 0.71 | 4864 | 1.24 |
| Equity | Global Health | Healthcare Services | 0.66 | 9261 | 1.15 |
| Foreign Equity | Regeneron Pharmaceuticals Inc | Pharmaceuticals | 0.64 | 162 | 1.13 |
| Foreign Equity | BECTON DICKINSON & CO | Health Care Equipment & Supplies | 0.44 | 445 | 0.77 |
| Equity | Cohance Life | Pharmaceuticals & Biotechnology | 0.42 | 13182 | 0.74 |
| Foreign Equity | AGILENT TECHNOLOGIES INC | Life Sciences Tools & Services | 0.34 | 440 | 0.60 |
| Foreign Equity | IQVIA HOLDINGS INC | Life Sciences Tools & Services | 0.31 | 264 | 0.54 |
| Foreign Equity | ILLUMINA INC | Life Sciences Tools & Services | 0.16 | 239 | 0.28 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Edelweiss Mutual Fund
Incorporation Date:
23-Aug-2007
Total Assets Managed (Cr.):
1,78,677.92
Trustee/s:
Eedelweiss Trusteeship Co
Chairman:
Rujan Panjwani
CEO / MD:
Ms. Radhika Gupta
CIO:
NA
President:
NA
Director/s:
Sandeep Bhandarker, Mr.Bhavesh Jain
Compliance Officer/s:
Mr. Jehzeel Master
Investor Service Officer/s:
Mr. Abdulla Chaudhari
Fund Manager/s:
Bhavesh Jain
Auditors:
Nangia & CO LLP(Edelweiss, Walker Chandiok & Co LLP
OTHER INFORMATION
Registered Office:
Edelwiess House, Off.C.S.T. Road, Kalina, Mumbai - 400 098.
Contact Nos:
022 40979737
Fax:
022 40979878
Email:
Website:
